Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Sweden Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20021
20034
20046
20052
20062
20076
200811
20097
201012
20113
20123
20133
20143
20155
20161
20173
20182
20203
20221
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75
Terminated8
Recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S17
AstraZeneca14
Boehringer Ingelheim14
Sanofi13
Eli Lilly and Company4
Hoffmann-La Roche4
Janssen Research & Development, LLC4
Takeda3
Bayer2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 287
Diabetes Mellitus25
Cardiovascular Diseases5
Glucose Metabolism Disorders4
Hypertension4
Dyslipidemias3
Obesity3
Diabetic Nephropathies2
Heart Failure2
Kidney Diseases2

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.